ORAMED PHARMACEUTICALS INC. - FORM 10-K - EX-23.1 - CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - November 25, 2016

Attached files

file filename
EX-10.32 - AMENDMENT TO THE AMENDED AND RESTATED TECHNOLOGY LICENSE AGREEMENT, DATED JULY 24, 2016, BETWEEN HEFEI TIANHUI INCUBATOR OF TECHNOLOGIES CO., LTD., ORAMED PHARMACEUTICALS, INC. AND ORAMED LTD. - ORAMED PHARMACEUTICALS INC.f10k2016ex10xxxii_oramed.htm
EX-10.6 - AMENDMENT, DATED JUNE 27, 2016, TO CONSULTING AGREEMENTS BY AND BETWEEN ORAMED LTD. AND KNRY, LTD., ENTERED INTO AS OF JULY 1, 2008, FOR THE SERVICES OF NADAV KIDRON. - ORAMED PHARMACEUTICALS INC.f10k2016ex10vi_oramed.htm
EX-31.1 - CERTIFICATION - ORAMED PHARMACEUTICALS INC.f10k2016ex31i_oramed.htm
EX-32.2 - CERTIFICATION - ORAMED PHARMACEUTICALS INC.f10k2016ex32ii_oramed.htm
EX-32.1 - CERTIFICATION - ORAMED PHARMACEUTICALS INC.f10k2016ex32i_oramed.htm
EX-31.2 - CERTIFICATION - ORAMED PHARMACEUTICALS INC.f10k2016ex31ii_oramed.htm
EX-10.34 - GENERAL TECHNICAL AGREEMENT BETWEEN ORAMED LTD. AND PREMAS BIOTECH PVT. LTD., DATED JULY 24, 2016 - ORAMED PHARMACEUTICALS INC.f10k2016ex10xxxiv_oramed.htm
EX-10.33 - SERVICE AGREEMENT, DATED AS OF JUNE 3, 2016, BETWEEN ORAMED LTD. AND XERTECS GMBH - ORAMED PHARMACEUTICALS INC.f10k2016ex10xxxiii_oramed.htm
EX-10.31 - AMENDMENT TO THE AMENDED AND RESTATED TECHNOLOGY LICENSE AGREEMENT, DATED JUNE 3, 2016, BETWEEN HEFEI TIANHUI INCUBATOR OF TECHNOLOGIES CO., LTD., ORAMED PHARMACEUTICALS, INC. AND ORAMED LTD. - ORAMED PHARMACEUTICALS INC.f10k2016ex10xxxi_oramed.htm
EX-10.25 - AMENDMENT TO EMPLOYMENT AGREEMENT, DATED JUNE 27, 2016, BETWEEN ORAMED LTD. AND JOSHUA HEXTER. - ORAMED PHARMACEUTICALS INC.f10k2016ex10xxv_oramed.htm
EX-10.22 - LETTER AGREEMENT, DATED AS OF FEBRUARY 5, 2013, BETWEEN ORAMED PHARMACEUTICALS INC. AND REGALS CAPITAL LP. - ORAMED PHARMACEUTICALS INC.f10k2016ex10xxii_oramed.htm
EX-10.7 - AMENDMENT, DATED JUNE 27, 2016, TO CONSULTING AGREEMENTS BY AND BETWEEN ORAMED LTD. AND KNRY, LTD., ENTERED INTO AS OF JULY 1, 2008, FOR THE SERVICES OF MIRIAM KIDRON. - ORAMED PHARMACEUTICALS INC.f10k2016ex10vii_oramed.htm
10-K - ANNUAL REPORT - ORAMED PHARMACEUTICALS INC.f10k2016_oramedpharma.htm

Exhibit 23.1

 

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-193557 and 333-190497) and Form S-8 (Nos. 333-213835, 333-199120, 333-190222 and 333-163919) of Oramed Pharmaceuticals Inc. of our report dated November 24, 2016 relating to the financial statements, which appears in this Form 10-K.

 

Tel-Aviv, Israel /s/ Kesselman & Kesselman
November 24, 2016 Certified Public Accountants (lsr.)
  A member firm of PricewaterhouseCoopers International Limited

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Kesselman & Kesselman, Trade Tower, 25 Hamered Street, Tel-Aviv 6812508, Israel,

P.O Box 50005 Tel-Aviv 6150001 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.com/il

 

Stock widget

Investing forum

ORAMED PHARMACEUTICALS INC. Reports